Source:  Travis Fain, WINSTON-SALEM JOURNAL, 6/9/11

A long-discussed tax credit meant to spur biotech innovation in North Carolina may have been resurrected Wednesday at the legislature. In the bill, private money would be invested in biotechnology companies chosen by state appointees. 

For more of this story, click here.